Company Filing History:
Years Active: 2014
Title: Innovations of Sreeinvasarao Vepachedu
Introduction
Sreeinvasarao Vepachedu is an accomplished inventor based in Vernon Hills, Illinois. He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory conditions. His work focuses on developing innovative solutions that address chronic health issues.
Latest Patents
Sreeinvasarao Vepachedu holds a patent for 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and their uses. This patent outlines a method for treating patients suffering from inflammation, chronic inflammation, pain, rheumatoid arthritis (RA), osteoarthritis, and osteoporosis. The method involves administering an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme.
Career Highlights
Throughout his career, Sreeinvasarao has been associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on innovative treatments that improve patient outcomes. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Sreeinvasarao has collaborated with notable colleagues, including Peer Jacobson and Lisa Maria Olson. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of medical treatments.
Conclusion
Sreeinvasarao Vepachedu's contributions to the field of medicine through his patent on 11-β-hydroxysteroid dehydrogenase type 1 inhibitors highlight his commitment to improving patient care. His work continues to inspire advancements in the treatment of chronic inflammatory conditions.